Epigallocatechin-3-Gallate Attenuates Myocardial Dysfunction via Inhibition of Endothelial-to-Mesenchymal Transition

Epigallocatechin-3-Gallate Attenuates Myocardial Dysfunction via Inhibition of Endothelial-to-Mesenchymal Transition

Cardiac tissue damage following ischemia leads to cardiomyocyte apoptosis and myocardial fibrosis. Epigallocatechin-3-gallate (EGCG), an active polyphenol flavonoid or catechin, exerts bioactivity in tissues with various diseases and protects ischemic myocardium; however, its association with the en...

Full description

Bibliographic Details
Main Authors:	Sejin Kim, Hyunjae Lee, Hanbyeol Moon, Ran Kim, Minsuk Kim, Seongtae Jeong, Hojin Kim, Sang Hyeon Kim, Soo Seok Hwang, Min Young Lee, Jongmin Kim, Byeong-Wook Song, Woochul Chang
Format:	Article
Language:	English
Published:	MDPI AG 2023-05-01
Series:	Antioxidants
Subjects:	EGCG myocardial infarction EndMT cardioprotection oxidative stress inflammation
Online Access:	https://www.mdpi.com/2076-3921/12/5/1059

Similar Items

Uncovering endothelial to mesenchymal transition drivers in atherosclerosis via multi-omics analysis
by: Qingyan Huang, et al.
Published: (2025-02-01)

Endothelial Reprogramming in Atherosclerosis
by: Lu Zhang, et al.
Published: (2024-03-01)

Antiallodynic effect of intrathecal epigallocatechin-3-gallate due to suppression of reactive oxygen species
by: Sang Soon An, et al.
Published: (2014-08-01)

Pioglitazone Alleviates Cardiac Fibrosis and Inhibits Endothelial to Mesenchymal Transition Induced by Pressure Overload
by: Wen-Ying Wei, et al.
Published: (2017-12-01)

In Vitro Evaluation of the Antiviral Activity of Polyphenol (-)-Epigallocatechin-3-Gallate (EGCG) Against Mayaro Virus
by: Pâmela Jóyce Previdelli da Conceição, et al.
Published: (2025-02-01)

PRELP secreted from mural cells protects the function of blood brain barrier through regulation of endothelial cell-cell integrity
by: Hongorzul Davaapil, et al.
Published: (2023-10-01)

Epigallocatechin-3-gallate at the nanoscale: a new strategy for cancer treatment
by: Wenxue Sun, et al.
Published: (2024-12-01)

Resveratrol-Elicited PKC Inhibition Counteracts NOX-Mediated Endothelial to Mesenchymal Transition in Human Retinal Endothelial Cells Exposed to High Glucose
by: Roberta Giordo, et al.
Published: (2021-02-01)

Histone modification of endothelial-mesenchymal transition in cardiovascular diseases
by: Qiu Jun, et al.
Published: (2022-12-01)

Epigallocatechin Gallate (EGCG), a Green Tea Polyphenol, Reduces Coronavirus Replication in a Mouse Model
by: Rackhyun Park, et al.
Published: (2021-12-01)

Formulation and Optimization of Nanospanlastics for Improving the Bioavailability of Green Tea Epigallocatechin Gallate
by: Eman A. Mazyed, et al.
Published: (2021-01-01)

Pathophysiology in Brain Arteriovenous Malformations: Focus on Endothelial Dysfunctions and Endothelial-to-Mesenchymal Transition
by: Jae Yeong Jeong, et al.
Published: (2024-08-01)

Endothelial-to-mesenchymal transition in the tumor microenvironment: Roles of transforming growth factor-β and matrix metalloproteins
by: Fei Du, et al.
Published: (2024-11-01)

Melatonin and (−)-Epigallocatechin-3-Gallate: Partners in Fighting Cancer
by: Lingyun Zhang, et al.
Published: (2019-07-01)

Reducing the potential allergenicity of amandin through binding to (−)-epigallocatechin gallate
by: Xin Luo, et al.
Published: (2022-12-01)

Effects of Epigallocatechin Gallate on the Stability of Epicatechin in a Photolytic Process
by: Shiuh-Tsuen Huang, et al.
Published: (2019-02-01)

Anti-Fibrosis Effect of Scutellarin via Inhibition of Endothelial–Mesenchymal Transition on Isoprenaline-Induced Myocardial Fibrosis in Rats
by: Hao Zhou, et al.
Published: (2014-09-01)

βklotho is essential for the anti‐endothelial mesenchymal transition effects of N‐acetyl‐seryl‐aspartyl‐lysyl‐proline
by: Rongfen Gao, et al.
Published: (2019-05-01)

Effect of Epigallocatechin gallate (EGCG) on Production of Dendritic Cells from Peripheral Blood Monocytes
by: Mohammad Ali Mofid Nakhaei, et al.
Published: (2020-11-01)

Anti-Amnesic Effects of Epigallocatechin Gallate on Scopolamine-Induced Learning and Memory Dysfunction in Sprague-Dawley Rats
by: Min-Jeong Kim, et al.
Published: (2021-12-01)

Approaches to overcome bioavailability inconsistencies of epigallocatechin gallate, a powerful anti-oxidant in green tea
by: Alina Furniturewalla, et al.
Published: (2022-10-01)

Antitumor Effect of Epigallocatechin Gallate and Vincristine in Mice with L5178Y Lymphoma
by: Georgina Almaguer, et al.
Published: (2023-11-01)

Combination Calcium Hydroxide and Epigallocatechin-3-gallate in Dentistry: A Narrative Review
by: Faza Aidah Hanifah, et al.
Published: (2023-08-01)

Characterization of the Synergistic Antioxidant Activity of Epigallocatechin Gallate (EGCG) and Kaempferol
by: Qiang Zhang, et al.
Published: (2023-07-01)

Bioinformatics analysis of MMP14+ myeloid cells affecting endothelial-mesenchymal transformation and immune microenvironment in glioma
by: Wei Luo, et al.
Published: (2024-03-01)

Protective Effect of Liposomal Epigallocatechin-Gallate in Experimental Gentamicin-Induced Hepatotoxicity
by: Adriana Elena Bulboacă, et al.
Published: (2022-02-01)

Expression of genes modulated by epigallocatechin-3-gallate in breast cancer cells
by: Bogacz Anna, et al.
Published: (2018-09-01)

Editorial: Endothelial-to-mesenchymal transition in cardiovascular disease
by: Mabruka Alfaidi, et al.
Published: (2023-10-01)

Unraveling the superiority of (−)‐gallocatechin gallate to (−)‐epigallocatechin‐3‐gallate in protection of diabetic nephropathy of db/db mice
by: Xin Xiao, et al.
Published: (2024-03-01)

Identification of Epigallocatechin-3-Gallate (EGCG) from Green Tea Using Mass Spectrometry
by: Iyyakkannu Sivanesan, et al.
Published: (2022-08-01)

(-)-Epigallocatechin-3-gallate Directly Binds Cyclophilin D: A Potential Mechanism for Mitochondrial Protection
by: Annan Wu, et al.
Published: (2022-12-01)

Biochemical, hematological, peripheral smear and weight evaluation of low dose Epigallocatechin Gallate in Diethylnitrosamine administered rats
by: Hadi Geylan, et al.
Published: (2023-03-01)

AMP-activated protein kinase mediates (-)-epigallocatechin-3-gallate (EGCG) to promote lipid synthesis in mastitis cows
by: Chunli Hu, et al.
Published: (2024-12-01)

Epigallocatechin gallate Mucoadhesive Gingival Patch as Potential Biomaterial to Regulate Macrophage and Lymphocyte Cells in Periodontitis: A Review
by: Sidarningsih Sidarningsih, et al.
Published: (2022-06-01)

Dengue Virus Infection Alters Inter-Endothelial Junctions and Promotes Endothelial–Mesenchymal-Transition-like Changes in Human Microvascular Endothelial Cells
by: Manuela Escudero-Flórez, et al.
Published: (2023-06-01)

Green Tea Epigallocatechin-3-Gallate Regulates Autophagy in Male and Female Reproductive Cancer
by: Sze Wan Hung, et al.
Published: (2022-07-01)

Bioaccessibility and Bioavailability of (-)-Epigallocatechin Gallate in the Bread Matrix with Glycemic Reduction
by: Lanqi Li, et al.
Published: (2022-12-01)

Beneficial Effects of Epigallocatechin Gallate in Preventing Skin Photoaging: A Review
by: Jiaqiang Sun, et al.
Published: (2024-11-01)

Epigallocatechin Gallate Enzymatic Alpha Glucosylation Potentiates Its Skin-Lightening Activity—Involvement of Skin Microbiota
by: Cloé Boira, et al.
Published: (2024-11-01)

Design, development, and characterization of lipid nanocarriers-based epigallocatechin gallate delivery system for preventive and therapeutic supplementation
by: Frias I, et al.
Published: (2016-10-01)